Johnson & Johnson

NYS : JNJ
Pharmaceuticals
New Brunswick NJ
IW Best50N/A
2012 Revenue (US$ Millions)$67,224
2011 Revenue (US$ Millions)$65,030
Revenue Growth (%)3.37%
Net Income (US$ Millions)$10,853
Common Shares Outstanding (Millions)$2,778
Earnings Per Share (US$)$3.86
Total Equity (US$ Millions)$64,826
Profit Growth (%)12.21
Profit Margin (%)16.14%
Return On Equity (%)19.01%
Long Term Debt (US$ Millions)$11,489
Debt To Equity Ratio (%)0.18%
Market Capitalization (US$ Millions)$193,049
Total Assets (US$ Millions)$121,347
Return on Assets (%)9.55
Current Assets (US$ Millions)$46,116
Inventories (US$ Millions)$7,495
Current Liabilities (US$ Millions)$24,262
Cost of Goods Sold (US$ Millions)$21,658
Asset Turnover0.55
Inventory Turnover3.14